Valens Groworks (MYMSF) Stock Price, News & Analysis

Company Overview

Valens Groworks (OTCMKTS:MYMSF) is a Canadian company that develops and manufactures cannabis and hemp-derived ingredients for the medicinal and adult-use markets. The company operates a fully licensed, Good Manufacturing Practices–compliant extraction facility in Kelowna, British Columbia, where it employs CO₂ and hydrocarbon extraction methods to produce oils, distillates and concentrates. In addition to extraction, Valens Groworks offers in-house formulation and white-label manufacturing services, providing turnkey solutions for licensed producers and consumer brands.

Beyond its core extraction business, Valens Groworks provides analytical testing services through an ISO/IEC 17025–accredited laboratory. This lab offers potency profiling, residual solvent analysis and contaminant screening, supporting Health Canada compliance and ensuring product safety. Valens Groworks has expanded its reach into the United States hemp market and has developed strategic partnerships with both domestic and international partners to supply bulk ingredients and finished formulations.

Founded in 2017, Valens Groworks has grown rapidly through facility expansions and strategic collaborations. The company is led by CEO David Bright, who brings experience in both pharmaceutical manufacturing and cannabis extraction. Under his direction, Valens Groworks has pursued rigorous quality standards, scaling its production capacity and broadening its service offerings to meet evolving market demands.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 87,700 shs
• Average Volume: 45,033 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MYMSF Stock Analysis - Frequently Asked Questions

How do I buy shares of Valens Groworks?

Shares of MYMSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:MYMSF
• CIK: N/A
• Web: www.valensgroworks.com
• Phone: N/A
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A